Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
XBIT
SELLXBiotech Inc. · Healthcare · United States · $69M · Avg Vol: $91K/d
29
StockRankGet insider-trade alerts
Q
36
V
36
M
47
P/E (TTM)
—
ROE
-25.9%
D/E
0.0x
Dividend %
—
Loading 1Y...
PRICE (1Y)-3.4%
SMA 50SMA 200
Close
$2.26
RSI (14)
25.8
52W High
$3.61
From 52W High
0.6%
SCORE BREAKDOWN
Quality
36
ROIC
-28.1%25.6
ROE
-25.9%28.8
GP/Assets
—N/A
Op. Margin
0.0%41.3
FCF/Assets
-26.8%13.3
Piotroski
111.4
Int. Cover
—N/A
D/E Ratio
0.00x97.8
Current Ratio
39.03x98.7
Value
36
P/E (TTM)
—N/A
EV/EBITDA
1.0x25.0
P/FCF
—N/A
P/B
0.5x96.6
P/S
—N/A
Div Yield
—N/A
Momentum
47
52W High %
63%42.9
RS 6M
-23%41.2
SMA 50/200
0.97x58.6
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+110%75.5
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$69M
P/E (Forward)
17.5x
Gross Margin
—
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of XBIT are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| XBIT | XBiotech Inc.(you) | $69M | 29 | SELL |
| ATRA | Atara Biotherapeutics, Inc. | $71M | 29 | SELL |
| LONA | LeonaBio, Inc. | $69M | 30 | SELL |
| PMVP | PMV Pharmaceuticals, Inc. | $66M | 25 | SELL |
| NRXS | NeurAxis, Inc. | $84M | 33 | SELL |
| ACET | Adicet Bio, Inc. | $73M | 21 | SELL |
| RLYB | Rallybio Corporation | $87M | 34 | SELL |
| PTHS | Pelthos Therapeutics Inc. | $90M | 24 | SELL |
| PLRX | Pliant Therapeutics, Inc. | $67M | 18 | STRONG SELL |
| XLO | Xilio Therapeutics, Inc. | $57M | 38 | HOLD |
Peer medians: ROE -25.5% · P/E 27.6x · Gross margin 50.5%